Axxam enters partnership to find MS and diabetes drug candidates
This article was originally published in Scrip
Executive Summary
The US Juvenile Diabetes Research Foundation (JDRF) and Fast Forward, the commercial drug development arm of the US National Multiple Sclerosis Society, have formed a partnership with Milan-based Axxam to develop treatments for type 1 diabetes and MS.